U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07529808) titled 'Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma' on April 01.
Brief Summary: This study is looking at how safe BHB810 is in adults with gastroesophageal adenocarcinoma (GEA) and other gastrointestinal (GI) cancers. The purpose of this study is also to look at: how well the study drug works, how the study drug moves into, through, and out of the body, and how your body reacts to the study drug. Participants will get an IV infusion of BHB810 every 2 weeks while on study treatment.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Gastric Cancer
Gastric Adenocarcinoma
Gastric (Stomach) Cancer...